Literature DB >> 16194545

Sandwich type ELISA and a fluorescent cytometric microbead assay for quantitative determination of hepatitis B virus X antigen level in human sera.

József Pál1, László Pálinkás, Zoltán Nyárády, Tamás Czömpöly, Ilona Marczinovits, György Lustyik, Younes Saleh Ali, György Berencsi, Roy Chen, Rudolf Varró, Alajos Pár, Péter Németh.   

Abstract

The hepatitis B virus X protein (HBxAg) is responsible for severe complications of HBV infections including primary hepatocellular carcinoma. A sandwich type ELISA and a flow cytometric microbead assay for quantitative determination of serum levels of Hbx-Ag are introduced. We have previously developed monoclonal antibody families against well-conserved epitopes on HbxAg, characterized by different immunohistochemical and immunoserological techniques. Special selection of the antibody pairs provided highly sensitive and highly specific tools for quantitative immunoassay development. The resulting assays were tested on human sera (208 samples) collected from patients suffering from different clinical forms of HBV infection. The sensitivity range of the sandwich type ELISA was between 4 and 2000 ng/ml as measured on both the recombinant antigen and the sera of chronic hepatitis patients. A further flow cytometric microbead assay was established and tested in parallel with the ELISA. The quantitative results of these two immunoserological techniques were in strong correlation and they were found to be highly specific and sensitive on clinical samples. The HBxAg ELISA technique is applicable for routine clinical laboratory measurements, and our HBxAg microbead technique is recommended for complex multiparametric measurements combined with other markers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194545     DOI: 10.1016/j.jim.2005.08.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Comprehensive regression analysis of hepatitis B virus X antigen level and anti-HBx antibody titer in the sera of patients with HBV infection.

Authors:  József Pál; Zoltán Nyárády; Ilona Marczinovits; Alajos Pár; Younes Saleh Ali; György Berencsi; Krisztián Kvell; Péter Németh
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

2.  Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV.

Authors:  Hang Zhang; Lian-Ying Wu; Shuai Zhang; Li-Yan Qiu; Nan Li; Xuan Zhang; Xue-Zhi Zhang; Chang-Liang Shan; Li-Hong Ye; Xiao-Dong Zhang
Journal:  J Biomed Biotechnol       Date:  2009-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.